Indicators on LY 3000328 You Should Know
Other medical trials in sufferers with non-Hodgkin's lymphoma [24] and sufferers with Innovative malignancy [14] have revealed also that zosuquidar did not drastically impact the pharmacokinetics of doxorubicin and experienced reasonable results to the pharmacokinetics of vincristine. These medical trials permitted that zosuquidar could safely and